Impact of COVID 19 on Psoriasis Patients
- Conditions
- The Impact of COVID19 on Psoriasis Patients
- Registration Number
- NCT05381402
- Lead Sponsor
- Cairo University
- Brief Summary
The main objective of this work is to investigate the effect of COVID-19 pandemic on psoriasis patients.
This work is designed as a cross-sectional survey based on a questionnaire directed to Egyptian psoriasis patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 230
Inclusion Criteria
- Psoriaisis patients
Exclusion Criteria
- Children
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Questionnaire 2-4 weeks To assess the effect of COVID 19 on psoriasis disease, treatment, follow up, vaccine
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link cytokine profiles in psoriasis patients to disease exacerbation during the COVID-19 pandemic?
How does the use of IL-23 inhibitors compare to traditional therapies in managing psoriasis during the pandemic in Egypt?
Which biomarkers, such as IL-23 receptor polymorphisms, predict psoriasis flare-ups in patients affected by the pandemic?
What adverse events are associated with psoriasis treatments like IL-17A inhibitors during the pandemic in Cairo University studies?
How do combination therapies involving JAK inhibitors and IL-12/23 blockers affect psoriasis in pandemic-related stress conditions?